Prognostic and Predictive Effect of TP53Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis

MLA

Ma, Xiaoli, et al. “Prognostic and Predictive Effect of TP53Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.” Journal of Thoracic Oncology, vol. 11, no. 6, June 2016, pp. 850–61. EBSCOhost, https://doi.org/10.1016/j.jtho.2016.02.002.

APA

Ma, X., Le Teuff, G., Lacas, B., Tsao, M. S., Graziano, S., Pignon, J.-P., Douillard, J.-Y., Le Chevalier, T., Seymour, L., Filipits, M., Pirker, R., Jänne, P. A., Shepherd, F. A., Brambilla, E., Soria, J.-C., & Hainaut, P. (2016). Prognostic and Predictive Effect of TP53Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Journal of Thoracic Oncology, 11(6), 850–861. https://doi.org/10.1016/j.jtho.2016.02.002

Chicago

Ma, Xiaoli, Gwénaël Le Teuff, Benjamin Lacas, Ming Sound Tsao, Stephen Graziano, Jean-Pierre Pignon, Jean-Yves Douillard, et al. 2016. “Prognostic and Predictive Effect of TP53Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.” Journal of Thoracic Oncology 11 (6): 850–61. doi:10.1016/j.jtho.2016.02.002.